| 24.94 0.42 (1.71%) | 08-18 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 37.73 | 1-year : | 46.7 |
| Resists | First : | 32.3 | Second : | 39.99 |
| Pivot price | 23.63  |
|||
| Supports | First : | 19.87 | Second : | 16.54 |
| MAs | MA(5) : | 25.16  |
MA(20) : | 22.91 |
| MA(100) : | 22.31 |
MA(250) : | 38.66 |
|
| MACD | MACD : | 1 |
Signal : | 0.8 |
| %K %D | K(14,3) : | 24.2 |
D(3) : | 26.3 |
| RSI | RSI(14): 57 |
|||
| 52-week | High : | 76.51 | Low : | 17.14 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ DOCS ] has closed below upper band by 35.5%. Bollinger Bands are 97.4% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 7 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 25.32 - 25.46 | 25.46 - 25.59 |
| Low: | 24.37 - 24.55 | 24.55 - 24.73 |
| Close: | 24.67 - 24.94 | 24.94 - 25.19 |
Doximity, Inc. provides a digital platform, hosted in the cloud, specifically designed for healthcare practitioners throughout the United States. This platform delivers a suite of specialized tools, empowering its members to connect with peers, streamline patient treatment, conduct remote consultations, access current medical information and research, and advance their professional careers. Its primary clientele consists of pharmaceutical companies and healthcare organizations. Established in 2010, the entity initially operated as 3MD Communications, Inc. before rebranding to Doximity, Inc. in June of that year. The company's corporate headquarters are situated in San Francisco, California.
Tue, 18 Aug 2026
Is Doximity (DOCS) Turning Rising AI Revenue Into Sustainable Profits Or Margin Trade-Offs? - webull.com
Mon, 17 Aug 2026
Doximity, Inc. (DOCS) Stock Analysis: Navigating a 17.38% Potential Upside Amidst Health Information Services Growth - DirectorsTalk Interviews
Mon, 17 Aug 2026
Bank of America Corp DE Grows Position in Doximity, Inc. $DOCS - MarketBeat
Sat, 15 Aug 2026
Clinical AI Use Surges as Revenue Climbs & Doctors Embrace New Tools - Streetwise Reports
Fri, 14 Aug 2026
DOCS|Doximity Inc|Price:25.030|Chg%:-1.560 - tradingkey.com
Fri, 14 Aug 2026
Royal Bank of Canada Has $4.81 Million Stock Position in Doximity, Inc. $DOCS - MarketBeat
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 127 (M) |
| Shares Float | 124 (M) |
| Held by Insiders | 2.8 (%) |
| Held by Institutions | 97.2 (%) |
| Shares Short | 20,730 (K) |
| Shares Short P.Month | 18,760 (K) |
| EPS | 0.83 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 5.19 |
| Profit Margin | 25.4 % |
| Operating Margin | 21.5 % |
| Return on Assets (ttm) | 10.9 % |
| Return on Equity (ttm) | 17.2 % |
| Qtrly Rev. Growth | 7.3 % |
| Gross Profit (p.s.) | 4.53 |
| Sales Per Share | 5.14 |
| EBITDA (p.s.) | 1.63 |
| Qtrly Earnings Growth | -52 % |
| Operating Cash Flow | 306 (M) |
| Levered Free Cash Flow | 240 (M) |
| PE Ratio | 29.69 |
| PEG Ratio | 0.5 |
| Price to Book value | 4.8 |
| Price to Sales | 4.84 |
| Price to Cash Flow | 10.36 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|